17618: 7-day study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in children from birth to less than 6 months with catheter-related arterial or venous thrombosis

Project: Research project

Project Details

StatusActive
Effective start/end date10/1/169/30/21

Funding

  • Bayer HealthCare Pharmaceuticals, Inc.
  • Bayer HealthCare Pharmaceuticals, Inc.